June 17 (Reuters) – Danaher Corp said on Thursday it
would buy privately held biotech company Aldevron in an all-cash
deal for about $9.6 billion.
(Reporting by Dania Nadeem in Bengaluru; Editing by Sriraj
Kalluvila)